{"raw_mentions": "None of the sentences in the provided text meet the criteria of containing all four required components: a specific molecule name, ID, or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50, and their variations), a specific numeric value for that metric, and a unit for that value. However, one sentence mentions EC50 values in a general context without providing specific numeric values or units:\n\n\nEC50 values were calculated in duplicate with the average of OD450 readings."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain sentences with a specific molecule name, a bioactivity metric (IC50, Ki, Kd, EC50), a numeric value, and a unit. The text primarily describes experimental methods and results, but does not provide specific data that meets the required criteria."}
{"raw_mentions": "Here are the extracted sentences with the required components:\n\nReferring to Table 3, the results show that all nanobodies bind strongly to WTRBD and that the EC50 values vary from 0.26 to 23.8 ng/mL.\nMost nanobodies (except B27) showed a stronger positive signal compared to ACE2, with EC50 values below 0.9 nanograms per milliliter.\nRemarkably, we found that most nanobodies (except B27) still had strong binding to ba.1rbd, with EC50 values below 107ng/mL.\nThe binding affinity (KD) is between 0.013 and 0.775 nM.\nNotably, a14 and B20 have strong binding affinities to the armin ba.1rbd with KD values of 0.065nM and 0.026nM, respectively (table 3)."}
{"final_json": [{"molecule_name": "nanobodies", "protein_target_name": "WTRBD", "binding_metric": "EC50", "value": "0.26 to 23.8", "unit": "ng/mL"}, {"molecule_name": "nanobodies", "protein_target_name": "ACE2", "binding_metric": "EC50", "value": "below 0.9", "unit": "nanograms per milliliter"}, {"molecule_name": "nanobodies", "protein_target_name": "ba.1rbd", "binding_metric": "EC50", "value": "below 107", "unit": "ng/mL"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "between 0.013 and 0.775", "unit": "nM"}, {"molecule_name": "a14", "protein_target_name": "armin ba.1rbd", "binding_metric": "KD", "value": "0.065", "unit": "nM"}, {"molecule_name": "B20", "protein_target_name": "armin ba.1rbd", "binding_metric": "KD", "value": "0.026", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n* Encouraging that A14 in group C showed cross-protective activity against all pseudoviruses, IC50 values varied from 83.93 to 316.6 ng/ml, suggesting its potential for targeting conserved RBD epitopes, see Table 5.\n* The three nanobodies of group a (a 31, B13 and B18) showed potent neutralizing activity against SARS-CoV-2WT, omnikow ba.1 and ba.4/5, with IC50 values between 117.6 and 1026 ng/ml, while group B, C2, showed limited neutralizing capacity (IC 50>2 \u03bcg/ml).\n* The neutralizing activity of the B13-B13-B13 homotrimer was the strongest, with a GMIC50 value of 20.83 ng/ml (Table 6).\n* The homodimers of A31-A31 and B13-B13 and the heterodimers of A31-C2 and B13-C2 have potent neutralizing activity against SARS-CoV-2WT, HMW BA.1 and BA.4/5, and IC50 values below 24 nanograms/milliliter.\n* Compared with BA.4/5, the neutralizing capacity of B13 to R346T mutant pseudovirus is obviously reduced, and the IC50 value is reduced by more than 10.8 times.\n* In addition, the neutralizing activity of monomer C2 against the N460K mutant pseudovirus was also reduced with an IC50> 5 \u03bcg/mL (fold change could not be calculated).\n* They were effective in neutralizing all seven single mutants with IC50 values below 100 nanograms/milliliter.\n* The neutralizing activity of these three multivalent nanobodies was slightly reduced (3.1-4.4 fold) for the R346T and/or N460K mutant pseudoviruses (Table 7)."}
{"final_json": [{"molecule_name": "A14", "protein_target_name": null, "binding_metric": "IC50", "value": "83.93 to 316.6", "unit": "ng/ml"}, {"molecule_name": "a 31, B13 and B18", "protein_target_name": null, "binding_metric": "IC50", "value": "117.6 to 1026", "unit": "ng/ml"}, {"molecule_name": "C2", "protein_target_name": null, "binding_metric": "IC50", "value": ">2", "unit": "\u03bcg/ml"}, {"molecule_name": "B13-B13-B13", "protein_target_name": null, "binding_metric": "GMIC50", "value": "20.83", "unit": "ng/ml"}, {"molecule_name": "A31-A31, B13-B13, A31-C2, B13-C2", "protein_target_name": null, "binding_metric": "IC50", "value": "<24", "unit": "nanograms/milliliter"}, {"molecule_name": "B13", "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "C2", "protein_target_name": null, "binding_metric": "IC50", "value": ">5", "unit": "\u03bcg/mL"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<100", "unit": "nanograms/milliliter"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Notably, the two homodimers (A31-A31, B13-B13), the two heterodimers (A31-C2, B13-C2) and one homotrimer (B13-B13) exhibited high neutralizing efficacy against SARS-CoV-2WT and HMG-Row BA.1 and BA.4/5, with IC50 values below 24 nanograms/milliliter."}
{"final_json": [{"molecule_name": "A31-A31, B13-B13, A31-C2, B13-C2, B13-B13", "protein_target_name": "SARS-CoV-2WT and HMG-Row BA.1 and BA.4/5", "binding_metric": "IC50", "value": "<24", "unit": "nanograms/milliliter"}]}
